Product
Attenuated HAV Vaccine
1 clinical trial
1 indication
Indication
Hepatitis AClinical trial
Phase 4 Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV VaccineStatus: Completed, Estimated PCD: 2015-12-01